MCM
MRNA icon

Makena Capital Management’s Moderna MRNA Stock Holding History

Makena Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48,300
Closed -$5.87M – 46
2023
Q2 		$5.87M Hold
48,300
– – 1.12% 40
2023
Q1 		$7.42M Hold
48,300
– – 1.41% 35
2022
Q4 		$8.68M Sell
48,300
-12,384
-20% -$2.02M 1.63% 31
2022
Q3 		$7.18M Hold
60,684
– – 1.2% 39
2022
Q2 		$8.67M Hold
60,684
– – 1.41% 28
2022
Q1 		$10.5M Buy
+60,684
New +$10.2M 1.27% 36

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Makena Capital Management's MRNA Position: Q3 2023 in Review

Makena Capital Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 48,300 shares — an estimated $5.87M sold.

Makena Capital Management first reported a position in MRNA in Q1 2022 and held it in 6 quarters. The position peaked at $10.5M in Q1 2022. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Makena Capital Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Makena Capital Management sold 48,300 Moderna shares in Q3 2023, an estimated $5.87M.
  • Makena Capital Management first reported a position in Moderna in Q1 2022 and held it in 6 quarters.
  • Makena Capital Management's Moderna position peaked at $10.5M in Q1 2022.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Makena Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.